The Cancer Profiling Global Market Report 2023, provides comprehensive information on the cancer profiling market across 60+ geographies in the seven regions - Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa for the 27 major global industries. The report covers a ten year historic period – 2010-2021, and a ten year forecast period – 2023-2032.
According to The Business Research Company’s Cancer Profiling Global Market Report 2023, the global cancer profiling market is poised for substantial growth, expected to surge from .59 billion in 2022 to .93 billion in 2023, boasting a significant compound annual growth rate (CAGR) of 12.6%. However, the Russia-Ukraine conflict has introduced temporary obstacles to the global economic recovery following the COVID-19 pandemic. This geopolitical turmoil has triggered economic sanctions on multiple nations, contributed to a rise in commodity prices, and caused disruptions in supply chains, ultimately leading to inflationary pressures across various goods and services worldwide. Nevertheless, the global cancer profiling market is projected to attain a size of .29 billion by 2027, fueled by a robust CAGR of 11.3%
Technological innovation stands out as a prominent and increasingly favored trend within the cancer profiling market. Prominent industry leaders are dedicating their resources to the development of cutting-edge technologies to bolster their market presence. A notable example is the initiative taken by Roche, a Switzerland-based multinational healthcare corporation. In December 2021, Roche introduced the AVENIO Edge System, a significant leap in next-generation sequencing (NGS) technologies. This novel system provides a completely automated solution for the sample preparation workflow, encompassing the entire journey from DNA sample input to the production of sequencing-ready libraries.
The cancer profiling market is segmented: 1) By Technology: Immunoassays, PCR (Polymerized Chain Reaction), NGS (Next-Generation Sequencing), Microarrays, In-Situ Hybridization 2) By Biomarker Type: Genomic Biomarkers, Protein Biomarkers 3) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancers 4) By Application: Research Applications, Clinical Applications, Screening, Diagnostics, Prognostics, Other Applications
North America was the largest region in the cancer profiling market in 2022.
Top 5 Major Key Players Are: Illumina Inc Qiagen N.V NeoGenomics Inc Sysmex Corporation HTG Molecular Diagnostics Inc
Table Of Contents 1. Executive Summary 2. Cancer Profiling Market Characteristics 3. Cancer Profiling Market Trends And Strategies 4. Cancer Profiling Market - Macro Economic Scenario 5. Cancer Profiling Market Size And Growth ....... 26. Africa Cancer Profiling Market 27. Cancer Profiling Market Competitive Landscape And Company Profiles 28. Key Mergers And Acquisitions In The Cancer Profiling Market 29. Cancer Profiling Market Future Outlook and Potential Analysis 30. Appendix
Learn About Us: The Business Research Company is a market intelligence firm that pioneers in market, company, and consumer research. TBRC’s specialist consultants are located globally and are experts in a wide range of industries that include healthcare, manufacturing, financial services, chemicals, and technology. The firm has offices located in the UK, the US, and India, along with a network of proficient researchers in 28 countries. Through the report businesses can gain a thorough understanding of the market’s size, growth rate, major drivers and leading players.
Like it? Share it!
About the Author
ramacharitbrc Joined: July 1st, 2020 Articles Posted: 1,960
